DEVELOPMENT AND VALIDATION OFRP-HPLC METHOD FOR ESTIMATION OF EDOXABAN TOSYLATE IN TABLET DOSAGE FORMS
Journal: Indian Drugs (Vol.57, No. 07)Publication Date: 2020-07-28
Authors : B. Anupama; P. Tejaswi; KNV. Chenchu Lakshmi; A. Vishwanadh;
Page : 47-51
Keywords : *For Correspondence E-mail: anurochi8@gmail.com;
Abstract
A rapid, simple and precise reversed phase high performance liquid chromatography (RP-HPLC) method was developed for the estimation of edoxabantosylate in tablets. The quantification was carried out using a Phenomenex C-18 column (250×4.6 mm i.d., 5µm particle size) in isocratic mode with mobile phase comprising of ammonium acetate buffer andacetonitrile in the ratio of 50:50 (V/V) at a flow rate 1 mL/min. The eluent was monitored at 240 nm. The retention time of the drug was 3.486 min. The calibration curve was linear in the concentration range of 5-25 µg/mL and per cent recovery ranged from 98.25-101.6.The developed method was validated as per ICH guidelines and the results obtained were satisfactory.The method can be applied for routine quality control analysis of edoxabantosylate in tablet dosage forms
Other Latest Articles
- STRUCTURAL SYNTHESIS BY CRITERION OF SUSTAINABILITY IN THE PROBLEM OF CLASSIFICATION OF OBJECTS-MULTIONS
- RP-HPLC AND HPTLC METHODS FOR THE ESTIMATION OF LUPEOL IN. HEMIDESMUS INDICUS LINN. ROOT EXTRACTS AND POLYHERBAL FORMULATION USING STANDARD MA
- ROLE OF OPTICAL COHERENCE TOMOGRAPHY IN EVALUATION OF PSEUDOPHAKIC CYSTOID MACULAR EDEMA (ON THE BASIS OF CLINICAL CASES)
- THE CONCEPT OF «ASCETIC EXPERIENCE» AND «ORTHODOX HUMANISM» IN THE WORKS OF PAISIUS VELICHKOVSKY
- LEAD IDENTIFICATION OF HYDROXAMATE DERIVATIVE AS SELECTIVE HDAC2 INHIBITOR USING COMPUTATIONAL APPROACHES
Last modified: 2020-10-26 19:47:29